Skip to main content
. 2021 Sep 15;22:245. doi: 10.1186/s12931-021-01833-6

Table 3.

Comparison of patients' symptoms at the time of admission and during hospitalization in the Modified ITT population

Symptoms—no. (%) Group P-value
Steroid + Azithromycin Azithromycin Lopinavir/Ritonavir Total
Respiratory distress 17 (17.9) 13 (13.5) 6 (6.0) 36 (12.4) 0.041
Chill 33 (34.7) 36 (37.5) 35 (35.0) 104 (35.7) 0.910
Cough 65 (68.4) 70 (72.9) 78 (78.0) 213 (73.2) 0.341
Dyspnea 63 (66.3) 66 (68.8) 66 (66.0) 195 (67.0) 0.866
Chest pain 23 (24.2) 30 (31.3) 29 (29.0) 82 (28.2) 0.671
Anorexia 59 (62.1) 62 (64.6) 61 (61.0) 182 (62.5) 0.817
Diarrhea 17 (17.9) 21 (21.9) 21 (21.0) 59 (20.3) 0.779
Vomiting 9 (9.5) 17 (17.7) 13 (13.0) 39 (13.4) 0.261
Abdominal pain 15 (15.8) 15 (15.6) 16 (16.0) 46 (15.8) 0.991
Sore throat 12 (12.6) 13 (13.5) 14 (14.0) 39 (13.4) 0.853
Myalgia 45 (47.4) 48 (50.0) 56 (56.0) 149 (51.2) 0.499
Arthralgia 8 (8.4) 21 (21.9) 12 (12.0) 41 (14.1) 0.025
Fatigue 54 (56.8) 54 (56.3) 62 (62.0) 170 (58.4) 0.671
Headache 32 (33.7) 32 (33.3) 38 (38.0) 102 (35.1) 0.745